Reuters news agency reported on Friday that the government of Argentina has said it received 904,000 doses of Chinese pharmaceutical company Sinopharm's COVID-19 vaccine in its first delivery on 25 February 2021.
Reportedly, this delivery, part of a deal for one million doses of the COVID-19 vaccine, arrived on a plane of Argentina's state carrier from Beijing late in the evening.
According to Argentina's government, the remaining 96,000 remaining doses of the agreement with Sinopharm will arrive in the next few days.
The Foreign Minister of Argentina, Felipe Sola, tweeted: "Everyone is going to get their vaccine and Argentina will be able to move forward."
Reportedly, the Sinopharm COVID-19 vaccines received will add to the 1.22 million doses of Russia's Sputnik V COVID-19 vaccines Argentina has already received, as well as to the 580,000 doses of Covishield, manufactured by the Indian Serum Institute in conjunction with AstraZeneca and Oxford University.
So far, Argentina has recorded over two million cases of COVID-19, with nearly 52,000 deaths.
GC Biopharma granted CMO rights for Curevo Vaccine's shingles vaccine
TransCode acquires Polynoma and secures USD25m investment from CK Life Sciences
Wasatch BioLabs adds three Oxford Nanopore-developed research-use-only assays to service portfolio
GSK and IQVIA expand vaccine track with local data to drive targeted public health action
AstraZeneca launches online platform to expand patient access to medications
Sanofi increases Sanofi Ventures funding by USD625m to boost biotech and digital health investments
GC Biopharma submits IND application in South Korea for Phase 1 trial of COVID-19 vaccine candidate
AusperBio completes patient enrolment in two Phase II clinical trials of AHB-137